首页> 外文期刊>The pharmaceutical journal >Remedying calcium and phosphate problems in chronic kidney disease
【24h】

Remedying calcium and phosphate problems in chronic kidney disease

机译:纠正慢性肾脏疾病中的钙和磷酸盐问题

获取原文
获取原文并翻译 | 示例
           

摘要

As renal function declines,a variety of metabolic disturbances manifest them-selves.Some patients will have altered biochemistry when their renal impairment is fairly mild,but by the time renal failure has become severe(a glomerular filtration rate or creatinine clearance below l0ml/minute),most patients have abnormal serum calcium and phosphate levels(see Panel 1 for normal reference ranges),falling vitamin D levels,and rising levels of parathyroid hormone(PTH).These result in a variety of clinical symptoms.Attempts to correct such abnormalities include the use of vitamin D and calcium-based phosphate binders.Treatment is usually successful initially but there are worries that the therapeutic use of these products can contribute to cardiovascular and soft-tissue calcification in the long term.
机译:随着肾功能的下降,各种代谢紊乱会表现出来。一些患者在肾脏损害相当轻度时会改变生化,但到肾衰竭变得严重时(肾小球滤过率或肌酐清除率低于10ml / min) ),大多数患者血清钙和磷酸盐水平异常(正常参考范围请参见第1页),维生素D水平下降,甲状旁腺激素(PTH)水平升高,从而导致多种临床症状。尝试纠正此类异常包括通常使用维生素D和钙基磷酸盐结合剂。治疗通常一开始会成功,但令人担忧的是,从长远来看,这些产品的治疗用途会导致心血管和软组织钙化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号